Genmab A/S
GMAB | NASDAQ
$34.69
-$0.05 (-0.14%)
At close: Sep 21, 2026, 4:00 PM ET
$34.45
-$0.24 (-0.69%)
Pre-market:
Sep 22, 2026, 9:02 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.16B | 899.32M | 1.05B | 1.02B | 924.81M | 105.23M | 6.44B | 5.54B | 779M | 603M | 4.68B | 4.71B | 4.17B | 2.83B | 5.14B | 4.09B | 3.16B | 2.12B | 2.62B | 2.31B | 1.97B | 1.58B |
Cost of Revenue | 84M | 65.24M | 80.76M | 58M | 56.99M | 6.18M | 337M | 273M | 28M | 27M | 126M | 79M | 21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 1.07B | 834.08M | 974.05M | 964M | 867.82M | 99.05M | 6.1B | 5.27B | 751M | 576M | 4.55B | 4.63B | 4.15B | 2.83B | 5.14B | 4.09B | 3.16B | 2.12B | 2.62B | 2.31B | 1.97B | 1.58B |
Operating Income | 407M | 225.83M | 242.27M | 459M | 359.92M | 27.67M | 2.16B | 2.1B | 236M | 116M | 1.67B | 1.69B | 1.47B | 417M | 2.58B | 1.93B | 1.25B | 514M | 809M | 890M | 787M | 532M |
Interest Income | 36M | 14.05M | 47.86M | 32M | 24.99M | 4.86M | 224M | 162M | 292M | 46M | 295M | 243M | 209M | 192M | 140M | 97M | 51M | 36M | 35M | 35M | 65M | 62M |
Pretax Income | 295M | 74.27M | 54.83M | 482M | 422.91M | 35.91M | 3.6B | 1.72B | 307M | 249M | 926M | 2.67B | 1.69B | 266M | 572M | 3.27B | 2.49B | 612M | 966M | 1.17B | 422M | 1.42B |
Net Income | 303M | 53.2M | 30.91M | 401M | 335.93M | 28.7M | 3.85B | 1.27B | 203M | 192M | 640M | 2.1B | 1.34B | 210M | 514M | 2.58B | 1.89B | 465M | 716M | 890M | 306M | 1.1B |
Selling & General & Admin | 205M | 166.61M | 207.37M | 148M | 143.97M | 18.54M | 1.25B | 865M | 129M | 125M | 934M | 860M | n/a | n/a | 921M | n/a | 633M | 452M | 512M | 306M | 264M | 201M |
Research & Development | 459M | 441.63M | 524.41M | 357M | 363.92M | 52.84M | 2.66B | 2.28B | 361M | 335M | 1.95B | 2.09B | 1.85B | 1.74B | 1.64B | 1.49B | 1.28B | 1.15B | 1.3B | 1.11B | 921M | 848M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 31M | 17M | 25M | n/a | n/a | n/a | 827M | 676M | n/a | 670M | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 664M | 608.24M | 731.79M | 505M | 507.89M | 71.38M | 3.94B | 3.17B | 515M | 460M | 2.88B | 2.95B | 2.68B | 2.42B | 2.56B | 2.16B | 1.92B | 1.61B | 1.81B | 1.42B | 1.19B | 1.05B |
Interest Expense | 110M | 112.41M | 43.87M | 3M | 9M | 735.9K | 54M | 18M | 19M | 4M | 6M | 8M | 7M | 6M | 5M | 6M | 6M | 4M | 3M | 4M | 430M | 3M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 748M | 673.48M | 812.54M | 563M | 564.88M | 77.56M | 4.28B | 3.44B | 543M | 487M | 3.01B | 3.03B | 2.7B | 2.42B | 2.56B | 2.16B | 1.92B | 1.61B | 1.81B | 1.42B | 1.19B | 1.05B |
Income Tax Expense | -8M | 21.08M | 23.93M | 81M | 86.98M | 7.21M | -243M | 453M | 104M | 57M | 286M | 566M | 359M | 56M | 58M | 690M | 598M | 147M | 250M | 281M | 116M | 328M |
Shares Outstanding (Basic) | 613.36M | 613.84M | 616.19M | 615.98M | 617.65M | 637.25M | 641.56M | 648.85M | 648.85M | 653.03M | 653.06M | 653.07M | 652.4M | 654.21M | 652.85M | 652.84M | 655.01M | 657.34M | 654.06M | 653.93M | 653.85M | 653.94M |
Shares Outstanding (Diluted) | 617.11M | 638.55M | 672.59M | 620.74M | 619.93M | 639.34M | 641.54M | 648.85M | 648.85M | 656.59M | 657.87M | 658.73M | 658.42M | 658.31M | 660.7M | 659.18M | 659.8M | 659.57M | 661.42M | 660.73M | 659.48M | 659.84M |
EPS (Basic) | 0.49 | 0.09 | 0.05 | 0.65 | 0.54 | 0.04 | 5.99 | 1.95 | 0.32 | 2.03 | 0.98 | 3.26 | 2.08 | 0.32 | 0.79 | 3.96 | 2.89 | 0.71 | 1.10 | 1.36 | 0.47 | 1.68 |
EPS (Diluted) | 0.49 | 0.08 | 0.05 | 0.65 | 0.54 | 0.04 | 5.99 | 1.95 | 0.31 | 2.02 | 0.97 | 3.23 | 2.06 | 0.32 | 0.78 | 3.92 | 2.87 | 0.71 | 1.08 | 1.35 | 0.46 | 1.66 |
EBITDA | 431M | 186.69M | 98.7M | 503M | 447.91M | 39M | 2.36B | 2.2B | 324M | 266M | 992M | 2.76B | 1.76B | 326M | 2.67B | 3.34B | 2.56B | 678M | 1.03B | 1.23B | 909.5M | 1.48B |
EBIT | 405M | 186.69M | 98.7M | 485M | 431.91M | 36.65M | 2.27B | 2.12B | 310M | 253M | 932M | 2.68B | 1.7B | 272M | 2.61B | 3.28B | 2.5B | 616M | 969M | 1.18B | 852M | 1.43B |
Depreciation & Amortization | 26M | n/a | n/a | 18M | 16M | 2.35M | 88M | 85M | 14M | 13M | 60M | 85M | 54M | 54M | 54M | 62M | 62M | 62M | 62M | 57.5M | 57.5M | 57.5M |
Add to Watchlist
Select watchlists to add or remove GMAB